Sunil Healthcare Ltd Share Price & Stock Analysis

Sunil Healthcare Ltd (BSE: 537253) is a New Delhi, Delhi-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹73 Cr, it ranks #3,506 by market cap among the 6,197 Indian listed companies on FinBizNet, and #71 of 86 in Medicinal Chemicals and Botanical Products. At ₹73.00 (as of 16 Nov 2026), the share price is 11.0% below its 52-week high of ₹82.00 and 21.7% above its 52-week low of ₹60.00. The share price is down 0.6% over one year and up 11.6% over three months.

Key Metrics

Current Price₹73.00
Market Cap₹73 Cr
BSE Code537253
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E Ratio18.2
Return on Equity5.86%
Return on Assets2.42%
52-Week Range₹60.00 – ₹82.00
1-Year Price Change-0.6%
3-Month Price Change+11.6%
Beta (1Y)0.23
HeadquartersNew Delhi, Delhi
Websitewww.sunilhealthcare.com

Shareholding and Delivery

Delivery averaged 86.9% of traded volume across 15 NSE sessions (23 Oct 2026 – 13 Nov 2026).

About Sunil Healthcare Ltd

Sunil Healthcare Limited engages in the manufacture and sale of empty hard gelatin, hydroxypropyl methylcellulose (HPMC), and pullulan capsules shells in India and internationally. Its products include EHG, BSE/TSE free, pearl, liquid fill, preservative free, stick free, flavored, SLS free, natural color, non-AZO, gelatin, HPMC/vegetable, and pullulan capsules. The company also provides ayurvedic products, such as haldi, ginger, vasaka, trifala, guduchi, salaki, punarvana, shatavari, hadjod, hingwastak, mulethi, arjuna, ashwagandha, and guggul extracts. The company offers its products under the SUNLOC brand name. Sunil Healthcare Limited was incorporated in 1973 and is based in New Delhi, India.

Products and Services

1. Sale of Capsule-This segment manufactures and sells empty hard gelatin and HPMC capsule shells. 2. Marketing of Food Products - Discontinued Operations-This segment markets food products. 3. Unallocated Assets-0 4. Segment Adjustment-0

Business Segments

1. Sale of Capsule-100%

Sunil Healthcare Ltd vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Sunil Healthcare Ltd₹73 Cr18.25.86%—-0.6%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Sunil Healthcare Ltd?

Sunil Healthcare Ltd is trading at ₹73.00, with a market capitalisation of ₹73 Cr.

Which sector does Sunil Healthcare Ltd belong to?

Sunil Healthcare Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Sunil Healthcare Ltd?

Sunil Healthcare Ltd has a P/E of 18.2 and a return on equity of 5.86%.

What is the stock symbol of Sunil Healthcare Ltd?

Sunil Healthcare Ltd is listed on the BSE under the scrip code 537253.

How has Sunil Healthcare Ltd's share price moved over the past year?

Sunil Healthcare Ltd's share price is down 0.6% over one year and up 11.6% over three months. Its 52-week range is ₹60.00 to ₹82.00.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.